1 |
Agresti, A. (1984). Analysis of Ordinal Categorical Data, John Wiley & Sons, New York
|
2 |
Birnbaum, Z. W. and Klose, O. M. (1957). Bounds for the variance of the Mann-Whitney statistic, The Annals of Mathematical Statistics, 28, 933-945
DOI
ScienceOn
|
3 |
Bryant, J. and Day, R. (1995). Incorporating toxicity considerations into the design of two-stage phase II clinical trials, Biometrics, 51, 1372-1383
DOI
ScienceOn
|
4 |
Conaway, M. R. and Petroni, G. R. (1995). Bivariate sequential designs for phase II trials, Biometrics, 51, 656-664
DOI
ScienceOn
|
5 |
Tubert-Bitter, P., Bloch, D. A. and Raynauld, J. (1995). Comparing the bivariate effects of toxicity and efficacy of treatments, Statistics in Medicine, 14, 1129-1141
DOI
ScienceOn
|
6 |
Petri, H., Leufkens, H., Naus, J., Silkens, R., van Hessen, P. and Urquhart, J. (1990). Rapid method for estimating the risk of acutely controversial side effects of prescription drugs, Journal of Clinical Epidemiology, 43,433-439
DOI
ScienceOn
|
7 |
Molenberghs, G. and Lesaffre, E. (1994). Marginal modeling of correlated ordinal data using a multivariate plackett distribution, Journal of the American Statistical Association, 89, 633-644
DOI
ScienceOn
|
8 |
Noether, G. E. (1987). Sample size determination for some common nonparametric tests, Journal of the American Statistical Association, 82, 645-647
DOI
ScienceOn
|
9 |
Norwood, P. K. and Sampson, A. R. (1988). A statistical methodology for postmarketing surveillance of adverse drug reaction reports, Statistics in Medicine, 7, 1023-1030
DOI
ScienceOn
|
10 |
Pocock, S. J., Geller, N. L. and Tsiatis, A. A. (1987). The analysis of multiple endpoints in clinical trials, Biometrics, 43, 487-498
DOI
ScienceOn
|
11 |
Thall, P. F. and Russell, K. E. (1998). A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase 1/11 clinical trials, Biometrics, 54, 251-264
DOI
ScienceOn
|
12 |
Simonoff, J. S., Hochberg, Y. and Reiser, B. (1986). Alternative estimation procedures for Pr(X < Y) in categorized data, Biometrics, 42, 895-907
DOI
ScienceOn
|
13 |
Thall, P. F. and Cheng, S. C. (1999). Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials, Biometrics, 55, 746-753
DOI
ScienceOn
|
14 |
Thall, P. F. and l.achin, J. M. (1988). Analysis of recurrent events:Nonparametric methods for randominterval count data, Journal of the American Statistical Association, 83, 339-347
DOI
ScienceOn
|
15 |
Conaway, M. R and Petroni, G. R (1996). Designs for phase II trials allowing for a trade-off between response and toxicity, Biometrics, 52, 1375-1386
DOI
ScienceOn
|
16 |
Cook, R J. and Farewell, V. T. (1994). Guidelines for monitoring efficacy and toxicity responses in clinical trials, Biometrics, 50, 1146-1152
DOI
ScienceOn
|
17 |
Cook, R J. (1996). Coupled error spending functions for parallel bivariate sequential tests, Biometrics, 52, 442-450
DOI
ScienceOn
|
18 |
Delong, E. R, Delong, D. M. and Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach, Biometrics, 44, 837-845
DOI
ScienceOn
|
19 |
Hochberg, Y. (1981). On the variance estimate of a Wilcoxon-Mann-Whitney statistic for group ordered data, Communications in Statistics - Theory and Method, A10, 1719-1732
DOI
ScienceOn
|
20 |
Jennison, C. and Turnbull, B. W. (1993). Group sequential tests for bivariate response: Interim analysis of clinical trials with both efficacy and safety endpoints, Biometrics, 49, 741-752
DOI
ScienceOn
|
21 |
Lehmann, E. L. (1975). Nonparametrics: Statistical Methods Based on Ranks, Holden-Day, San Francisco
|
22 |
Levine, M. N., Guyatt, G. H., Gent, M., De Pauw, S., Goodyear, M. D., Hryniuk, W. M., Arnold, A., Findlay, B., Skillings, J. R. and Bramwell, V. H. (1988). Quality of life in stage II breast cancer: An instrument for clinical trials, Journal of Clinical Oncology, 6, 1798-1810
DOI
|
23 |
Lipsitz, S. R., laird, N. M. and Harrington, D. P. (1990). Maximum likelihood regression methods for paired binary data, Statistics in Medicine, 9, 1517-1525
DOI
ScienceOn
|